NCT05552833

Brief Summary

Patients with chronic obstructive lung disease (COPD) suffer from a progressive loss of lung function that leads to poor quality of life, and often invalidity and early death. Regular exercise can improve quality of life in these patients, but the health care system lack the underlying mechanism of exercise-induced improvement in COPD and it is widely thought not to have any effect on lung function. The aim of the present study is to investigate to which extent lung tissue mass and rest-to-exercise diffusion capacity changes differ in COPD patients compared to the healthy state. In order to design prospective clinical trials on the putative impact of high-intensity interval training (HIIT) investigating these parameters, and a secondary aim is to assess the feasibility of such a study in terms of patient inclusion, adherence and methodology.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 5, 2022

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 13, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 23, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

October 17, 2022

Status Verified

October 1, 2022

Enrollment Period

1.9 years

First QC Date

September 13, 2022

Last Update Submit

October 13, 2022

Conditions

Keywords

High intensity interval training (HIIT)Lung growthDiffusion capacityBlood flowLung tissue massOxygen extraction

Outcome Measures

Primary Outcomes (2)

  • Lung tissue mass

    Change in lung weight in COPD patients compared to matched controls using CT-scans.

    CT-scans at baseline and at 12 week follow up.

  • Rest-to-exercise diffusion capacity

    Change in rest-to-exercise pulmonary diffusion capacity between COPD patients and matched healthy controls measured by DLNO/CO.

    DLNO/CO measured at baseline and at 12 week follow up.

Secondary Outcomes (2)

  • Rest-to-exercise pulmonary perfusion ratio change

    At baseline and at 12 week follow up

  • Rest-to-exercise leg blood flow change in COPD

    At baseline and at 12 week follow up

Other Outcomes (38)

  • Rest-to-exercise cardiac output change

    At baseline and at 12 week follow up

  • VO2peak (and estimated VO2max)

    At baseline and at 12 week follow up

  • VO2 verification bout

    At baseline and at 12 week follow up

  • +35 more other outcomes

Study Arms (2)

COPD patients

EXPERIMENTAL

This arm will consist of only COPD patients.

Other: High intensity interval training

Healthy controls

EXPERIMENTAL

This arm will consist of age and BMI matched healthy controls.

Other: High intensity interval training

Interventions

Participants will undergo 12 weeks of supervised HIIT training (3 times per week). The HIIT protocol will consist of 4x4 min.

COPD patientsHealthy controls

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women
  • years
  • COPD (GOLD stage I to III)
  • Forced expiratory volume in 1 sec (FEV1)/forced vital capacity ratio (FVC) \< 0.8, FEV1 \< 90% of predicted value
  • Modified Medical Research Council score (mMRC 0 - 3)
  • Resting arterial oxygenation \> 90%
  • Do not fulfil the physical activity recommendations by the Danish Health Authority
  • Men and women
  • years
  • Normal FEV1, FVC, FEV1/FVC, and single-breath diffusion capacity
  • Same sex, age (± 3 years) and BMI (± 10%)
  • Do not fulfil the physical activity recommendations by the Danish Health Authority (19)
  • BMI 18-35

You may not qualify if:

  • Symptoms of ischaemic heart disease
  • Known heart failure
  • Previous severe or current COVID-19
  • Unable to complete or understand HIIT training
  • Claudication
  • Symptoms of disease within 2 weeks prior to the study
  • Participation in pulmonary rehabilitation within 6 months
  • Known malignant disease
  • Pregnancy
  • Unstable cardiac arrhythmic disease
  • Renal or liver dysfunction
  • COPD
  • Asthma
  • Known ischaemic heart disease
  • Known heart failure
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre for Physical Activity Research (CFAS)

Copenhagen, 2100, Denmark

RECRUITING

Rigshospitalet

Copenhagen, 2100, Denmark

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Ronan Martin Griffin Berg, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: 12 COPD will undergo the intervention in one arm and 12 healthy, age and BMI matched individuals will undergo the same intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, DMSc, Associate Professor, Principal investigator

Study Record Dates

First Submitted

September 13, 2022

First Posted

September 23, 2022

Study Start

September 5, 2022

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

October 17, 2022

Record last verified: 2022-10

Locations